SAB Biotherapeutics (SABS) News Today

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

$4.72

+0.11 (+2.39%)

(As of 04/16/2024 ET)

Source

Source	Headline
	SAB Leaps on Completing Latest Cohort msn.com - April 16 at 11:03 AM
	SAB Biotherapeutics Provides SAB-142 Trial Update globenewswire.com - April 16 at 7:15 AM
	SAB Biotherapeutics to Present at INNODIA Annual Meeting globenewswire.com - April 8 at 7:15 AM
	SAB Biotherapeutics: Strong Financial Position and Promising SAB-142 Pipeline Merit Buy Rating markets.businessinsider.com - April 4 at 7:44 AM
	SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference globenewswire.com - April 4 at 7:15 AM
	SAB Biotherapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags finance.yahoo.com - April 1 at 11:25 AM
	SAB Biotherapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags finance.yahoo.com - April 1 at 11:25 AM
	SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results globenewswire.com - March 29 at 7:15 AM
	SAB Collaborates With Naval Medical Research To Develop Potential Influenza Treatment; Stock Drops markets.businessinsider.com - March 25 at 3:41 PM
	SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment globenewswire.com - March 25 at 10:15 AM
	SAB Biotherapeutics to Present at the BIO CEO & Investor Conference globenewswire.com - February 23 at 8:00 AM
	SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference finance.yahoo.com - February 8 at 12:42 PM
	SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference finance.yahoo.com - February 8 at 12:42 PM
	SAB Biotherapeutics Names Samuel Reich Chief Executive marketwatch.com - February 2 at 10:20 AM
	SAB Biotherapeutics' Executive Chairman Reich Takes On Addl. Role As CEO markets.businessinsider.com - February 2 at 10:20 AM
	SAB Biotherapeutics Announces Executive Leadership Change finance.yahoo.com - February 2 at 10:20 AM
	marketbeat.com - January 29 at 9:58 AM
	SAB Biotherapeutics, Inc.: SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement finanznachrichten.de - January 24 at 6:44 AM
	SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement finance.yahoo.com - January 23 at 8:13 PM
	Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Praxis Precision Medicines (PRAX) and SAB Biotherapeutics (SABS) markets.businessinsider.com - January 8 at 10:57 PM
	Individual investors are SAB Biotherapeutics, Inc.'s (NASDAQ:SABS) biggest owners and were rewarded after market cap rose by US$535m last week finance.yahoo.com - January 5 at 9:00 AM
	marketbeat.com - January 5 at 6:04 AM
	SAB Biotherapeutics, Inc.: SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split finanznachrichten.de - January 3 at 7:24 PM
	SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split finance.yahoo.com - January 2 at 7:10 PM
	Here's Why SAB Biotherapeutics, Inc. (SABS) Is a Great 'Buy the Bottom' Stock Now finance.yahoo.com - December 8 at 3:18 PM
	VerifyMe And 3 Other Stocks Under $2 Insiders Are Buying msn.com - December 1 at 3:14 PM
	SAB Biotherapeutics Starts Human Clinical Trial of Diabetes Treatment finance.yahoo.com - November 29 at 2:52 PM
	EXCLUSIVE: SAB Biotherapeutics Kickstarts Phase 1 Study For Its Lead Type 1 Diabetes Hopeful In Australia msn.com - November 29 at 9:47 AM
	SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes finance.yahoo.com - November 29 at 9:47 AM
	SAB Biotherapeutics, Inc.: SAB Biotherapeutics Appoints Katie Ellias to the Board of Directors finanznachrichten.de - November 20 at 1:54 PM
	SAB Biotherapeutics Appoints Katie Ellias to the Board of Directors finance.yahoo.com - November 20 at 8:54 AM
	SAB Biotherapeutics, Inc.: SAB Biotherapeutics Announces Q3 2023 Financial Results and Provides Company Updates finanznachrichten.de - November 14 at 4:22 PM
	SAB Biotherapeutics GAAP EPS of -$0.10 msn.com - November 14 at 4:22 PM
	SAB Biotherapeutics 3Q Loss Narrows, Completes $67.1M in Financing finance.yahoo.com - November 14 at 4:22 PM
	SAB Biotherapeutics Announces Q3 2023 Financial Results and Provides Company Updates finance.yahoo.com - November 14 at 9:16 AM
	SAB Biotherapeutics Announces Completion of $67.1 Million Financing to Advance Potential Disease-Modifying Treatment for Type 1 Diabetes finance.yahoo.com - November 14 at 9:16 AM
	SAB Biotherapeutics to Present at Piper Sandler Healthcare Conference finance.yahoo.com - November 9 at 9:32 AM
	SAB Biotherapeutics files to sell 412.7M units to noteholders msn.com - November 6 at 1:53 PM
	SAB Biotherapeutics Appoints Michael G. King Jr. as Chief Financial Officer finance.yahoo.com - October 24 at 8:11 AM
	Analysts Are Bullish on Top Healthcare Stocks: SAB Biotherapeutics (SABS), Elevance Health (ELV) markets.businessinsider.com - October 19 at 12:17 PM
	SAB Biotherapeutics Receives Australian Approval to Commence Phase 1 Clinical Trial of SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes finance.yahoo.com - October 19 at 12:17 PM
	SAB Biotherapeutics’ Financial Stability and Potential Growth: A Comprehensive Analysis of Edward White’s Buy Rating markets.businessinsider.com - October 6 at 2:51 PM
	Secured Financing and Promising Clinical Developments Bolster Buy Rating for SAB Biotherapeutics markets.businessinsider.com - October 6 at 9:51 AM
	SAB Biotherapeutics Approves Appointment of Andrew Moin to Board of Directors finance.yahoo.com - October 5 at 8:43 AM
	SAB Biotherapeutics Approves Appointment of Andrew Moin to Board of Directors finance.yahoo.com - October 5 at 8:43 AM
	SAB Biotherapeutics Will Sell $130 Million Shares of Preferred Stock to Advance Diabetes Treatment finance.yahoo.com - October 3 at 1:38 PM
	EXLUSIVE: SAB Biotherapeutics To Raise Up To $130M Via Preferred Equity To Advance Development Of Lead Diabetes Candidate finance.yahoo.com - October 2 at 12:34 PM
	SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes finance.yahoo.com - October 2 at 12:34 PM
	SAB Biotherapeutics GAAP EPS of -$0.14 seekingalpha.com - August 22 at 8:39 AM
	SAB Biotherapeutics (SABS) Gets a Buy from Chardan Capital markets.businessinsider.com - August 22 at 8:39 AM

Get SAB Biotherapeutics News Delivered to You Automatically

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

SABS Media Mentions By Week

SABS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SABS
News Sentiment
▼
0.44

0.66
▲
Average
Medical
News Sentiment

SABS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SABS Articles
This Week
▼
5

1
▲
SABS Articles
Average Week

Get SAB Biotherapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:SABS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

SAB Biotherapeutics (SABS) News Today

SABS Media Mentions By Week

SABS Media Sentiment

SABS News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info